Tumor necrosis factor‐α and the failing human heart–TNFα and heart failure

Clinical Cardiology

Volumn 18, Issue 4 S, 1995, Pages IV20-IV27

  Oral, Hakan ^a   Kapadia, Samir ^a   Nakano, Masayuki ^a   Torre‐Amione, Guillermo ^a   Lee, Joseph ^a   Lee‐Jackson, Dorellyn ^a   Young, James B ^a   Mann, Douglas L ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

congestive heart failure; cytokines; tumor necrosis factor alpha (TNF )

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; CHEMICAL PHENOMENA; CONGESTIVE HEART FAILURE; HEART CONTRACTION; HUMAN; IMMUNOLOGY; REVIEW;

ADULT; DEPRESSION, CHEMICAL; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL CONTRACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029365927     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.4960181605     Document Type: Article

References (72)

1. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
2. Increased concentrations of tumour necrosis factor in ‘cachectic’ patients with severe chronic heart failure
3. Tumour necrosis factor‐alpha in severe congestive cardiac failure
4. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure: Relation to nitric oxide‐dependent vasodilation in the forearm circulation
5. Increased circulating cytokines in patients with myocarditis and cardiomyopathy
6. Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines
7. The cardiovascular response of normal humans to the administration of endotoxin
8. Tumor necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome
9. TNF‐induced cardiomyopathy
10. An endotoxin‐induced serum factor that causes necrosis of tumors
11. Tumor nectosis factor (TNF)
12. Cellular basis for the negative inotropic effects of tumor necrosis factor‐alpha in the adult mammalian heart
13. Interleukin I and tumor necrosis factor inhibit cardiac myocyte b̃‐adrenergic responsiveness
14. Cytokines
15. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions
16. Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock
17. Endotoxin induced TNFα gene and protein expression in adult feline myocardium
18. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia
19. Genes for IFN‐b̃‐2 (IL‐6), tumor necrosis factor, and IL‐I are expressed at high levels in the organs of normal individuals
20. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
21. Soluble tumor necrosis factor binding proteins modulate the negative inotropic effects of TNF‐α in vitro
22. Cytokine receptors: Structure and signal transduction
23. Isolation and characterisation of a tumor necrosis factor binding protein from urine
24. Two tumor necrosis factor‐binding proteins purified from human urine
25. Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor
26. A human inhibitor of tumor necrosis factor α
27. A tumor necrosis factor binding protein is present in human biological fluids
28. A tumor necrosis factor‐binding protein purified to homogeneit from human urine protects cells from tumor necrosis factor toxicity
29. Characterization of a tumor necrosis factor α (TNF‐α) inhibitor: Evidence of immunological cross‐reactivity with the TNF receptor
30. Shock and tissue injury induced by recombinant human cachectin
31. Neutralisation of endogenous tumor necrosis factor ameliorates the severity of myosin‐induced myocarditis
32. Expression of tumor necrosis factor in human acute cardiac rejection: An immunohistochemical and immunoblowing study
33. Mediation of cardio protection by transforming growth factor‐b̃
34. Mechanism of cytokine inhibition of b̃‐adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Impairment of signal transduction
35. A new method for assessment of cultured cardiac myocyte contractility detects immune factor‐mediated inhibition of b̃‐adrenergic responses
36. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock
37. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor‐α in conscious dogs
38. Tumor necrosis factor challenges in canines: Patterns of cardiovascular dysfunction
39. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system
40. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage‐conditioned medium
41. 2+‐independent nitric oxide synthase in the myocardium
42. Nitric oxide synthase activities in human myocardium
43. 2+ current
44. Effects of 8‐Bromo‐GMP on contraction and on inotropic response of ferret cardiac muscle
45. 2+ current is regulated by cyclic GMP‐dependent protein kinase in mammalian cardiac myocytes
46. 2) synthesis in rat cardiomyocytes
47. Role of nitric oxide in antagonistic effects of transforming growth factor‐b̃ and interleukin‐1b̃ on the beating rate of cultured myocytes
48. Nitric oxide as a secretory product of mammalian cells
49. Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis
50. Comparative effects of interleukin‐1 and tumor necrosis factor‐α on collagen production and corresponding procollagen mRNA levels in human dermal fibroblasts
51. Pleural mesothelial cell response to inflammation: Tumor necrosis factor‐induced mitogenesis and collagen synthesis
52. Tumor necrosis factor alpha (TNFα) and transforming growth factor α1 (TGFb̃1) stimulate fibronectin synthesis and the transdifferentiation of fat‐storing cells in the rat liver into myofibroblasts
53. Correlation between tumor necrosis factor‐α (TNFα)‐induced cytoskeletal changes and human collagenase gene induction
54. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts
55. Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo
56. Effect of free fatty acids on myocardial function and metabolism in the ischemic dog heart
57. Increased levels of serum neopterin and decreased production of neutphil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor‐alpha
58. Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure
59. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo
60. Comments on ‘plasma cytokine and endotoxin levels in patients with sepsis syndrome’
61. Cytokine antagonists circulate in the blood of patients with advanced congestive heart failure
62. Measuring circulating cytokines
63. c‐myc mRNA in cytoskeletal‐bound polysomes in fibroblasts
64. G‐0 protein as signal transducer in the pertussis toxin‐sensitive phosphatidylinositol pathway
65. Effects of vesnarinone on morbidity and mortality in patients with heart failure
66. Tumors secreting human TNF/cachectin induce cachexia in mice
67. Through thick and thin: Wasting, obesity, and TNFα
68. Recombinant human tumor necrosis factor induces reductions in food intake and body weight in mice